87 results
6-K
EX-4.4
ENLV
Enlivex Therapeutics Ltd
29 May 24
Enlivex Therapeutics Closes up to $15 Million Registered Direct Offering
4:20pm
that such calculation is in compliance with Section 13(d) of the Exchange Act and the Holder is solely responsible for any schedules required to be filed
6-K
EX-4.5
ENLV
Enlivex Therapeutics Ltd
29 May 24
Enlivex Therapeutics Closes up to $15 Million Registered Direct Offering
4:20pm
that such calculation is in compliance with Section 13(d) of the Exchange Act and the Holder is solely responsible for any schedules required to be filed
6-K
EX-4.2
ENLV
Enlivex Therapeutics Ltd
29 May 24
Enlivex Therapeutics Closes up to $15 Million Registered Direct Offering
4:20pm
responsible for any schedules required to be filed in accordance therewith and the calculations required under this Section 2(e). To the extent
6-K
EX-4.1
ENLV
Enlivex Therapeutics Ltd
29 May 24
Enlivex Therapeutics Closes up to $15 Million Registered Direct Offering
4:20pm
that the Company is not representing to the Holder that such calculation is in compliance with Section 13(d) of the Exchange Act and the Holder is solely responsible
6-K
EX-1.1
ENLV
Enlivex Therapeutics Ltd
29 May 24
Enlivex Therapeutics Closes up to $15 Million Registered Direct Offering
4:20pm
, in which case the Company shall be responsible for the reasonable fees and expenses of no more than one such separate counsel. The Company … are several and not joint with the obligations of any other Purchaser, and no Purchaser shall be responsible in any way for the performance or non
6-K
EX-4.3
gclog
29 May 24
Enlivex Therapeutics Closes up to $15 Million Registered Direct Offering
4:20pm
6-K
EX-99.2
0733d7m8
11 Apr 24
Enlivex Announces Topline Results of Its Phase II Trial Evaluating Allocetra™ In Patients With Sepsis
8:13am
6-K
EX-99.1
9yos2
29 Mar 24
Report of Foreign Private Issuer
4:30pm
6-K
EX-99.1
daunq1
31 Mar 23
Report of Foreign Private Issuer
4:30pm
6-K
EX-99.1
8e6cpi jn079gq
5 Oct 22
Notice of Annual General Meeting of Shareholders
3:00pm
UPLOAD
4tp4k7wu si0q7gpxmk
2 May 22
Letter from SEC
12:00am